Promising Penny Stocks To Add to Your Watchlist – January 29th

Nanovibronix, Richtech Robotics, and Perspective Therapeutics are the three Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares of small companies, typically trading for less than $5 per share and often listed on over-the-counter markets or smaller exchanges. They tend to have low market capitalizations, limited liquidity, sparse public information, and higher volatility and fraud risk, making them speculative and risky for investors. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Nanovibronix (FEED)

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.

Read Our Latest Research Report on FEED

Richtech Robotics (RR)

Richtech Robotics Inc. develops, manufactures, deploys, and sells robotic solutions for automation in the service industry. The company offers indoor transport and delivery, sanitation, and food and beverage automation solutions, such as ADAM and ARM worker robots; delivery robots, including Matradee, Matradee X, Matradee L, Richie, and Robbie; and cleaning robots comprising DUST-E SX, and DUST-E MX, as well as accessories, such as bus tubs, cup holders, magnetic tray cases, smartwatches, table location systems, and tray covers.

Read Our Latest Research Report on RR

Perspective Therapeutics (CATX)

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers.

Read Our Latest Research Report on CATX

Recommended Stories